<DOC>
	<DOCNO>NCT00877370</DOCNO>
	<brief_summary>Critically ill patient intensive care unit often receive continuous hemodialysis treat kidney failure . Ertapenem antibiotic often used patient . Continuous dialysis may remove ertapenem , put patient risk inappropriate treatment infection . This study determine much ertapenem remove continuous hemodialysis .</brief_summary>
	<brief_title>Pharmacokinetics Ertapenem Continuous Venovenous Hemodialysis</brief_title>
	<detailed_description>Subjects receive CVVHD receive one gram dose ertapenem . Serial blood sample 24 hour take assess ertapenem blood concentration time . Spent dialysate urine sample ( ) also measure ertapenem content determine much drug remove CVVHD kidney . A pharmacokinetic evaluation make determine appropriate dose drug patient receive CVVHD achieve pharmacokinetic pharmacodynamic goal .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Hospitalized ICU Receiving Continuous hemodialysis Prescribed ertapenem Informed consent grant &lt; 18 year age Allergy ertapenem carbapenem antibiotic Severe , lifethreatening reaction penicillin cephalosporins Patients experience history CNS disorder ( eg : seizure , stroke ) Patients experience CNS infection Inability complete 24 hour CVVHD Concurrent use extracorporeal therapy extracorporeal membrane oxygenation , plasmapheresis intermittent hemodialysis Inability obtain informed consent Pregnant and/or breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>ertapenem</keyword>
	<keyword>continuous hemodialysis</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>